Company
United StatesPublic company, NASDAQ: PRAXPraxis Precision Medicines, Inc. (NASDAQ: PRAX), Boston, MA – FDA Inspections
Inspection records and compliance data for Praxis Precision Medicines, Inc. in Boston, MA. 1 FDA inspection on record, last inspected July 10, 2026. Publicly traded as NASDAQ: PRAX.
Company Profile
This profile covers Praxis Precision Medicines, Inc. based in Boston, MA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected July 10, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 10, 2026 | Not classified | Human Drugs | 1332596 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Praxis Precision Medicines, Inc.
Stock ticker
PRAX
Exchange
NASDAQ
Share price
$324.76
Market cap
$9.1B
Price as of
November 13, 2026
FEI Number
3021572675
Address
99 High St Fl 30, Boston, MA 02110-2320, United States
Country
United States
ID: 7a5bffdc-c834-4914-8ec7-9d1538b0cd75